Table 4.
Hematology parameter1 | Combined classification2 | Time 13 | Time 24 | Time 35 | SE | Treatment6 (Trt) | Time (T) | Trt × T |
---|---|---|---|---|---|---|---|---|
WBCs, ×103 cells/µL |
Healthy | 10.4 | 9.7 | 9.1 | 0.34 | 0.0037 | 0.3366 | 0.4437 |
sBRD | 10.3 | 10.1 | — | 0.78 | ||||
BRD-no-con | 10.8 | 10.4 | 10.1 | 0.51 | ||||
BRD-con | 10.7 | 10.8 | 11.2 | 0.45 | ||||
Neutrophils, ×103 cells/µL |
Healthy | 3.1 | 2.6x | 2.2x | 0.26 | 0.001 | 0.1136 | 0.0018 |
sBRD | 2.7 | 2.1x | – | 0.56 | ||||
BRD-no-con | 2.9 | 3.8xy | 2.6xy | 0.38 | ||||
BRD-con | 2.7a | 4.1b,y | 3.8ab,y | 0.33 | ||||
Lymphocytes, ×103 cells/µL |
Healthy | 6.9 | 6.6 | 6.5 | 0.21 | 0.1952 | 0.0062 | 0.1241 |
sBRD | 7.1 | 7.4 | 7.6 | 0.48 | ||||
BRD-no-con | 7.6 | 6.3 | 7.0 | 0.32 | ||||
BRD-con | 7.6 | 6.3 | 6.9 | 0.28 | ||||
N:L | Healthy | 0.46 | 0.40x | 0.36x | 0.05 | 0.0002 | 0.0448 | 0.0004 |
sBRD | 0.39 | 0.31x | – | 0.10 | ||||
BRD-no-con | 0.42 | 0.63xy | 0.41xy | 0.07 | ||||
BRD-con | 0.36a | 0.69b,y | 0.62b,y | 0.06 | ||||
Basophils, ×103 cells/µL |
Healthy | 0.12 | 0.12xy | 0.12 | 0.006 | 0.0334 | 0.0029 | 0.0196 |
sBRD | 0.13 | 0.14x | 0.15 | 0.013 | ||||
BRD-no-con | 0.12 | 0.09y | 0.13 | 0.009 | ||||
BRD-con | 0.12a | 0.11a,xy | 0.14b | 0.007 | ||||
Monocytes, ×103 cells/µL |
Healthy | 0.45 | 0.41 | 0.37 | 0.023 | 0.1376 | 0.1685 | 0.7377 |
sBRD | 0.44 | 0.49 | – | 0.053 | ||||
BRD-no-con | 0.46 | 0.46 | 0.40 | 0.035 | ||||
BRD-con | 0.48 | 0.44 | 0.46 | 0.031 | ||||
Eosinophils, ×103 cells/µL |
Healthy | 0.27 | 0.22 | 0.25 | 0.035 | 0.0935 | 0.3718 | 0.1847 |
sBRD | 0.21 | 0.42 | 0.33 | 0.082 | ||||
BRD-no-con | 0.24 | 0.16 | 0.33 | 0.055 | ||||
BRD-con | 0.17 | 0.17 | 0.21 | 0.048 | ||||
RBCs, ×106 cells/µL |
Healthy | 10.7 | 10.6 | 10.5 | 0.16 | 0.001 | 0.1131 | 0.7346 |
sBRD | 10.6 | 10.4 | – | 0.37 | ||||
BRD-no-con | 10.5 | 10.1 | 10.6 | 0.24 | ||||
BRD-con | 10.3 | 9.6 | 9.9 | 0.21 | ||||
Hemoglobin, g/dL |
Healthy | 13.8 | 13.5 | 13.5 | 0.21 | 0.0072 | 0.0206 | 0.8926 |
sBRD | 13.6 | 13.3 | – | 0.44 | ||||
BRD-no-con | 13.6 | 12.9 | 13.2 | 0.30 | ||||
BRD-con | 13.5 | 12.6 | 12.9 | 0.27 | ||||
Hematocrit, % |
Healthy | 36.2 | 35.3 | 34.9 | 0.55 | 0.0107 | 0.0058 | 0.8440 |
sBRD | 35.8 | 34.7 | – | 1.19 | ||||
BRD-no-con | 35.6 | 33.5 | 34.6 | 0.80 | ||||
BRD-con | 35.4 | 33.0 | 33.5 | 0.71 | ||||
Platelets, ×103 cells/µL |
Healthy | 503.3x | 541.3 | 556.1x | 22.1 | <0.0001 | 0.0132 | 0.0281 |
sBRD | 692.8y | 648.5 | – | 51.5 | ||||
BRD-no-con | 560.4xy | 528.0 | 609.6xy | 33.9 | ||||
BRD-con | 540.2a,xy | 539.6a | 714.7b,y | 29.5 |
1WBCs, white blood cells; N:L, neutrophils:lymphocytes; RBCs, red blood cells.
2Classification is based on the combination of CRS and TUS score. Healthy (n = 68), sBRD (n = 14), BRD-no-con (n = 38), and BRD-con (n = 30). A matched healthy control calf corresponding to each individual BRD case was selected retrospectively from the nearest pen to compare hematology variables at the same sample times.
3Seven days before BRD detection.
4Day of BRD diagnosis.
5Seven days of BRD detection.
6Treatment (TRT) refers to classification groups (Healthy, sBRD, BRD-no-con, and BRD-con).
a–cWithin rows, Lsmeans differ from pre-BRD baseline by P ≤ 0.05.
x–zWithin columns, Lsmeans differ between treatments by P ≤ 0.05.
Lsmeans with the same letter are not significantly different.